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Background: Follistatin (FST), a secreted glycoprotein, is intrinsically linked to muscle hypertrophy. To explore
the function of duck FST in myoblast proliferation and differentiation, the pEGFP-FST eukaryotic expression
vector was constructed and identiﬁed. The biological activities of this vector were analyzed by transfecting
pEGFP-FST into cultured duck myoblasts using Lipofectamine™ 2000 and subsequently determining the mRNA
expression proﬁles of FST and myostatin (MSTN).
Results: The duck pEGFP-FST vector was successfully constructed and was conﬁrmed to have high
liposome-mediated transfection efﬁciency in duck myoblasts. Additionally, myoblasts transfected with
pEGFP-FST had a higher biological activity. Signiﬁcantly, the overexpression of FST in these cells
signiﬁcantly inhibited the mRNA expression of MSTN (a target gene that is negatively regulated by FST).
Conclusions: The duck pEGFP-FST vector has been constructed successfully and exhibits biological activity
by promoting myoblast proliferation and differentiation in vitro.
© 2014 Pontiﬁcia Universidad Católica de Valparaíso. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Follistatin (FST), also referred to as FSH inhibiting protein (FSP) [1],
is a single chain, glycosylated polypeptide that has an inhibitory
effect on follicle-stimulating hormone (FSH). Previous research has
demonstrated that FST is expressed in almost all tissues (e.g.,
kidney, trabecular meshwork and testis [2,3,4]), and that FST
possesses extensive physiological functions in these tissues. FST
regulates the development and regenerative processes of the
kidney, and modulates the production of androgen. The FST gene is
considered a candidate gene for the induction of muscle myoﬁber
hypertrophy, and recent research has shown that FST functions in
the development of muscle in mice [5]. Previous research has also
indicated that FST may promote muscle ﬁber hypertrophy in a
mouse model via activation of satellite cells, causing them to fuse
into muscle ﬁbers. For example, both an FST transgene [6], and
transfected FST that were delivered by an adeno-associated virus
[7], have an effect on satellite cell proliferation and muscle ﬁber
hypertrophy in mice [8]. Additionally, the depletion of FST in miceidad Católica de Valparaíso.
araíso. Production and hosting by Elleads to prenatal lethality associated with impaired muscle
development [9]. FST is also known to be a powerful inhibitor of
myostatin (MSTN), a negative regulator of muscle development
[10]. MSTN knock-out mice displayed a two-fold increase in muscle
mass compared with wild-type mice [6], and over-expression of FST
in these animals lead to an increase in muscle mass that was four-fold
greater than in normal mice [11]. These studies suggest a close
relationship between FST and skeletal muscle hypertrophy in
mammals. In contrast, the roles of FST in skeletal muscle remain
largely uncharacterized in birds.
Peking ducks (Anas platyrhynchos domestica) constitute a
considerable portion of the poultry meat market. We previously
cloned the duck FST coding domain sequence (CDS), and found that
the sequence in ducks was different from that in mammals [12]. We
also cloned the duck FST gene into a prokaryotic expression vector
and puriﬁed a duck FST recombinant fusion protein. When
administered into adult duck leg muscle tissues, the recombinant FST
protein was shown to possess biological activity and promote muscle
growth [13]. To better understand the mechanism of FST in regulating
muscle hypertrophy in birds, we sought to construct a eukaryotic
expression vector for duck FST with biological activity in promoting
myoblast proliferation and differentiation.
In the present study, duck FST cDNA was inserted into the
eukaryotic expression vector pEGFP-N1 to generate pEGFP-FST,
which was then transfected into duck myoblasts where it exhibited
some biological activities. These results provide technical support
for basic research on the regulation of FST in skeletal musclesevier B.V. All rights reserved.
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subject.2. Materials and methods
2.1. Animals
Pekingduck eggs at 13 d of incubationwere obtained randomly from
the Sichuan Agricultural University Waterfowl Breeding Experimental
Farm. All of the eggs were incubated under the same conditions at a
temperature of 37 ± 0.5°C and a humidity of 86–87%.2.2. Construction of duck pMD-19T-FST and pEGFP-FST
Based on the total sequence length of the duck FST CDS [12], a pair of
primers was designed: forward 5′ TTGATATCGGGGACTGCTGGCTCCGG
CAG 3′; and reverse 5′ GGCTCGAGTTACC ACTCTAGAATGGAA 3′. The
following PCR ampliﬁcation cycles were performed: 5 min at 95°C for
an initial denaturation, 34 cycles of 30 s at 95°C, 30 s at 51°C for
primer annealing, an extension time of 60 s at 72°C, and 10 min at
72°C for the ﬁnal extension. The PCR products were electrophoresed
in 1.5% (w/v) agarose gels and stained with ethidium bromide. Next,
the PCR products were puriﬁed and recovered using an agarose gel
extraction kit (Watson Biomedical Inc., Shanghai, China). The puriﬁed
FST fragments were ligated to pMD-19T vector (Takara, Japan) at a
9:1 ratio for 1 h at 16°C. For ampliﬁcation, 10 μL of pMD-19T-FST
solution was transformed into 50 μL E. coli DH5a cells, with the
speciﬁc steps as follows: incubation on ice (-6°C) for 30 min, and heat
stress (42°C) for 45 s, cold stress (-6°C) for 1 min. Positive clones
were isolated and shaken in a thermostatic culture cradle overnight at
37°C, and a random analysis of 20 clones was then conducted using
PCR. Finally, sequencing analysis was conducted by Invitrogen Life
Technologies.
Based on restriction enzyme mapping of the CDS fragments of duck
FST and the multiple cloning sites present in the pEGFP-N1 vector
(Clontech, CA, USA), Xho I and EcoRI were chosen as the insertion
sites. A pair of primers was designed representing the two ends of the
FST CDS, and an XhoI restriction enzyme site was inserted upstream of
the FST CDS. The forward primer was designed as follows: 5′ CTCTCG
AGTTAAATCAGAGGATCCA 3′ (where CTCGAG is the XhoI site). The
reverse primer was designed as follows: 5′ CGGAATTCTTACCACTCTAG
AATGG 3′ (where GAATTC is the EcoRI site). The FST CDS should be in
the same reading frame as the downstream EGFP gene sequence to
ensure co-expression of the fusion protein.
To improve the ampliﬁcation efﬁciency, the CDS of the FST genewas
ampliﬁed using the following PCR cycles: 4 min at 95°C for initial
denaturation, 34 cycles of 45 s at 95°C, 40 s at 52°C for primer
annealing, an extension time of 60 s at 72°C, and 10 min at 72°C for a
ﬁnal extension. The PCR product was recovered and cloned into the
pMD-19T simple vector, and was then transformed into competent
DH5α cells. Positive clones were isolated and shaken overnight at
37°C. Plasmids were extracted from sense colonies using the TIANprep
Mini Plasmid Kit (Tiangen, Beijing, China) and digested using XhoI
and EcoRI (Takara). The reaction mixture was as follows: 4 μL of the
FST gene, 2.5 μL (10×) T4 DNA ligase buffer, 1 μL pEGFP-N1, 1 μL of
T4 DNA ligase (NEB, USA) and 16.5 μL of sterilized water. A cDNA
fragment of 1032 bp was recovered and directly ligated into a
pEGFP-N1 eukaryotic expression vector that had been digested
with XhoI and EcoRI, and then transformed into competent DH5α
cells. Positive clones were isolated and shaken overnight at 37°C
and conﬁrmed via sequencing by Invitrogen Life Technologies. The
identiﬁcation results for pMD-19T-FST and pEGFP-FST, as well as a
map of the ﬁnal recombinant plasmid (pEGFP-FST), are shown in
Fig. 1.2.3. Cell culture
Primary duck myoblast cultures were prepared according to the
method described by Liu et al. [14]. Myoblasts from 13-d-old eggs
were isolated based on a differential attachment and were cultured
in Dulbecco's modiﬁed Eagle's medium (DMEM, Sigma-Aldrich
Japan, Tokyo, Japan) supplemented with 10% FBS and antibiotics
(100 U/mL penicillin and 100 μg/mL streptomycin). The cells were
maintained in 5% CO2 at 37°C. When conﬂuent, the cells were
transferred to a 6-well plate using a split ratio of 1:2.
2.4. pEGFP-FST transfection
Duck myoblasts were transfected with pEGFP-FST when the cells
reached 70% conﬂuency. The cells were divided into three groups:
pEGFP-FST, pEGFP-N1 and control. Transfection was carried out
using Lipofectamine™ 2000 (Beyotime, Shanghai) according to the
manufacturer's instructions. In each well, cells were transfected
with the following liposomal transfection mixture: 12.5 μL (2.5 μg)
of DNA, 47.5 μL of DMEM and 15 μL of liposomes. After 12 and 24 h,
the cells were collected to conduct subsequent assays. All experiments
were performed in triplicate.
2.5. Analysis of transfection efﬁciency
After 24 h, the expression of EGFP in myoblasts was observed under
a ﬂuorescence microscope (Nikon TE2000, Japan), and the number of
cells in every well exhibiting positive EGFP expression was counted
(Fig. 2).
2.6. MTT assay and morphological observation
Myoblast viability was determined based on the amount of MTT
reduced to formazan. After transfection with either pEGFP-FST or
pEGFP-N1, culture medium containing 0.5 mg/mL MTT was added
to each well and the cells were incubated at 37°C for 3 h, at which
point DMSO was added to dissolve the formazan crystals. The
absorbance at 570 nm was then measured. Twenty-four hours after
transfection, changes in cell morphology were observed and the
number of myoblasts in the three groups was recorded (Fig. 3).
2.7. Real-time PCR analysis
Total RNAwas isolated fromduckmyoblasts using the Trizol reagent
(Takara, Dalian, China), and the concentration of each RNA sample was
determined using a NanoVue Plus spectrophotometer (GE Healthcare
Bio-Sciences AB, Sweden). All RNA samples were subsequently
adjusted to the same concentration. A SYBR Prime Script RT-PCR Kit
(TaKaRa, Dalian, China) was then used for reverse transcription-PCR
(RT-PCR) according to the manufacturer's protocol. The relative mRNA
expression of FST and MSTN was analyzed by real-time PCR using the
IQ™5 System (Bio-Rad, USA) with β-actin (Genbank No: EF667345.1)
and GAPDH (Genbank No: GU564233.1) serving as reference genes.
The primer information is listed in Table 1. The PCR reactions were
carried out in a 96-well plate in a 25 μL reaction volume. Each reaction
mixture contained 12.5 μL of SYBR® Green I PCR Master Mix (Takara,
Japan), 2.5 μL of normalized template DNA, 0.5 μL of each primer and
9.5 μL of sterile ultrapure water. The relative expression of FST and
MSTN was calculated using the “normalized relative quantiﬁcation”
method followed by 2-△△Ct. PCR reactions were performed in
triplicate for each sample.
2.8. Statistical analysis
The real-time PCR data were subjected to analysis of variance
(ANOVA), and the means were compared for signiﬁcance using
Fig. 1. Identiﬁcation of duck pMD-19T-FST and pEGFP-FST. (a) Identiﬁcation of the recombinant plasmid pMD-19T-FST by enzyme digestion (XhoI and EcoRI) and 1.5% agarose gel
electrophoresis after a PCR reaction. M: DL5000 Marker; 1: plasmid pMD-19T-FST digested with EcoRI and XhoI. (b) Digestion of pEGFP-FST with XhoI and EcoRI. M: DL5000Marker; 1:
pEGFP-N1; 2: pEGFP-FST recombinant plasmid enzyme digestion bands. (c) The map of the ﬁnal cloned recombinant plasmid (pEGFP-FST).
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Fig. 2. Lipofection efﬁciency of myoblasts (ﬂuorescence images taken 24 h post-transfection). (a) The expression of EGFP in duck myoblasts (×100). Note: a, b and c show pEGFP-FST
transfected myoblasts (transfection); d, e and f show pEGFP-N1-transfected myoblasts; and g, h and i show the control. Comparing by rows, a, d and g show the shape of myoblasts
(Cy3); b, e and h reﬂect the green ﬂuorescent protein (FITC); and c, f and i show the overlap of the two images. The cells containing EGFP were identiﬁed as positive cells. (b) This
ﬁgure shows that the highest efﬁciency of transfection was obtained with the pEGFP-FST group and the pEGFP-N1 group. The efﬁciencies were 77% and 70%, respectively. The number
of myoblasts containing EGFP protein was counted and analyzed using Image-Pro Plus 6.0 software (Media Cybernetics, Bethesda, MD). The arrows in (c) indicate the expression of
green ﬂuorescent EGFP.
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Fig. 3.Effect of pEGFP-FST transfection onmyoblastmorphology and vitality in vitro (×100). (a) pEGFP-FST group, B: pEGFP-N1 group, C: Control group,D: The number ofmyoblasts in the
pEGFP-FST group, the pEGFP-N1 group and the control group. The number ofmyoblasts was counted and analyzed using Image-Pro Plus 6.0 software (Media Cybernetics, Bethesda, MD).
E: Vitality of duck myoblasts after transfection with pEGFP-FST for 24 h. The results are presented as the mean ± SEM (n = 3). Data were analyzed by ANOVA and Tukey's test.
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of less than 0.05 was considered to be statistically signiﬁcant.3. Results
3.1. Identiﬁcation of duck pMD-19T-FST and pEGFP-FST
Complete digestion of the pMD-19T-FST vector with XhoI and EcoRI
produced the expected fragments (Fig. 1a).
The target gene fragmentwas successfully ligated to the 5′ endof the
EGFP cDNA, guaranteeing that the CDS of FST was in the same reading
frame as EGFP. The predicted 1032 bp fragment was obtained by
complete digestion of the recombinant pEGFP-FST plasmid with XhoI
and EcoRI (Fig. 1b).Table 1
Primers used in this study.
Gene Primer sequence (5′–3′) Product length
(bp)
Annealing temperature
(°C)
FST
F ACAACTTACCCAAGCGAGTGTG 145 58
R CATCTTCCTCTTCTTCCTCTGG
MSTN
F GCACTGGTATTTGGCAGAGTATT 142 60
R TCACCTGGTCCTGGGAAAGT
β-actin
F GCTATGTCGCCCTGGATTTC 168 55
R CACAGGACTCCATACCCAAGAA
GAPDH
F AAGGCTGAGAATGGGAAAC 254 50
R TTCAGGGACTTGTCATACTTC
Note: F, R — forward and reverse primers, respectively.3.2. Transfection efﬁciency analysis of the duck expression vector
pEGFP-FST in vitro
The expression of the EGFP reporter gene was observed using
ﬂuorescence microscopy (Nikon, Japan) 24 h after transfection
(Fig. 2). The results showed that, in both the pEGFP-FST group and
the pEGFP-N1 group, large numbers of myoblasts expressed green
ﬂuorescent protein. EGFP was expressed in 77% of the cells in the
pEGFP-FST group and 70% of the cells in the pEGFP-N1 group
(Fig. 2b), suggesting that both pEGFP-FST and pEGFP-N1 can be
effectively transfected into myoblasts, resulting in high levels of
EGFP expression.
3.3. Effect of pEGFP-FST transfection on myoblast morphology and vitality
in vitro
Myoblast cell counts were signiﬁcantly increased after pEGFP-FST
was successfully transfected into duck myoblasts, with the majority
of cells forming myotubes by fusion as shown in Fig. 3a–c. The
numbers of myoblasts in both the pEGFP-N1 and controls group
were signiﬁcantly lower than in the pEGFP-FST group, with only a
few cells fusing into myotubes, as shown in Fig. 3d (P b 0.05).
There were no obvious differences in either the number of
myoblasts or myoblast morphology between the pEGFP-N1 group
and the control group. These results suggested that transfection
using Lipofectamine™ 2000 was not toxic to the cells, and that FST
could promote the proliferation and differentiation of myoblasts.
Additionally, myoblast viability increased signiﬁcantly in the
pEGFP-FST group, as demonstrated by the MTT assay. As shown in
Fig. 3e, the pEGFP-FST group produced a higher OD value than the
pEGFP-N1 group or the control group (P b 0.05). Collectively, these
results indicate that pEGFP-FST increases myoblast viability and
signiﬁcantly promotes the proliferation and differentiation of
myoblasts.
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MSTN
As shown in Fig. 4a, FSTmRNA expressionwas signiﬁcantly higher in
the pEGFP-FST group as compared to the pEGFP-N1 or control groups (P
b 0.01), suggesting that FST was successfully transfected intomyoblasts
and efﬁciently expressed. Twenty-four hours post-transfection, the
expression of FST in myoblasts was higher than at 12 h, indicating that
the transfection efﬁciency increased over time. As shown in Fig. 4b,
MSTN mRNA expression in the pEGFP-FST group was signiﬁcantly
lower than that in the pEGFP-N1 or control groups (P b 0.05).
Nevertheless, the expression of MSTN increased over time, indicating
that the expression of MSTN also occurred in a time-dependent
manner. Taken together, these results demonstrate that the
over-expression of FST inhibits the expression of MSTN.4. Discussion
The eukaryotic expression system is an effective way to explore the
functions of new genes in vitro, and can be used in both themedical and
agricultural ﬁelds. The eukaryotic expression vector pEGFP-C1-BMP-2
was originally generated and transfected into COS-7 cells to explore
the function of BMP in bone and cartilage development [15]. Since the
pEGFP vector carries the EGFP gene, any expressed fusion proteins
from the pEGFP plasmid will contain both the target protein and the
EGFP protein. Additionally, the pEGFP plasmid has been demonstrated
to have no toxic effects on cells [16]. Therefore, to study the effect of
duck FST on myoblasts and to lay the foundation for a thorough study
of the role of FST in duck muscle development, we generated a
pEGFP-FST eukaryotic expression vector.
To investigate the biological activity of pEGFP-FST in myoblasts, the
pEGFP-FST eukaryotic vector was inserted into duck myoblasts via
liposome-mediated transfection. The results showed that pEGFP-FST
possessed speciﬁc biological activities. The transfection efﬁciency of
pEGFP-FST was signiﬁcantly higher than that of either pEGFP-N1
or the control vector, and pEGFP-FST enhanced duck myoblast
viability while mildly promoting myoblast proliferation and
differentiation. Twenty-four hours post-transfection, pEGFP-FST
displayed high transfection efﬁciency (77%) that was consistent with
the previous research showing a high transfection efﬁciency for the
pIRES2-EGFP-myf6 vector in bovine myoblasts [17]. However, further0
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Fig. 4. Effect of pEGFP-FST transfection on the mRNA expression of FST and MSTN after 12 and
expression of MSTN after transfection for 12 and 24 h. Duck β-actin (EF667345) and GADPH (A
and “*”above the bar indicates P b 0.05.study is needed to determine the underlying mechanisms by which
FST affects duck myoblast proliferation and differentiation.
FST is a secreted glycoprotein that promotes muscle hypertrophy.
Previous research has shown that FST is capable of inducing muscle
hypertrophy by activating satellite cells and inﬂuencing the
expression of myogenesis-related genes [13]. Additionally,
inhibition of MSTN by FST is a recently identiﬁed novel mechanism
for the promotion of muscle hypertrophy [8]. MSTN is a strong
negative regulator of skeletal muscle mass. In mammals, FST can
inhibit the binding of the C-terminus of the MSTN dimer to the
ActRIIB receptor in transfected COS cells [6]. Using a two-hybrid
analysis, it was also shown that FST and mature MSTN form a
complex in both yeast and mammalian cells [10]. Additionally,
systemic administration of FST in mice inhibits the wasting effect
of MSTN in vivo [18]. In our research, FST mRNA expression
increased signiﬁcantly after transfection with pEGFP-FST, with
higher expression of FST at 24 h than at 12 h. Our research is
consistent with that of Sun et al. [17], who also showed that the
expression of pEGFP-MyoD in myoblasts is higher at 24 h than 12 h
and 36 h. To determine the role of FST in duck myoblasts, as well as
to further validate the effect of FST over-expression on MSTN, we
examined their expression levels of both genes in pEGFP-FST,
pEGFP-N1 and control myoblasts at two stages (Fig. 4b). The results
showed that the expression levels of MSTN were signiﬁcantly lower
in the pEGFP-FST group than in the other two groups at both stages,
and that the expression of MSTN in the 24 h group was higher than
that in the 12 h group. The level of MSTN expression did not
change remarkably in the pEGFP-N1 or the control group,
indicating that the over-expression of FST signiﬁcantly inhibited
the expression of MSTN. In duck myoblasts, transfected pEGFP-FST
may serve as an inhibitor to down-regulate the expression of
MSTN. Moreover, the results demonstrated that the mechanism by
which FST inhibits MSTN in duck was similar to what has been
previously reported in mammals, and also showed that duck
pEGFP-FST possessed speciﬁc biological activity resulting in the
inhibition of MSTN mRNA expression in myoblasts. Thus, these
results further demonstrate the successful construction of
pEGFP-FST.
Taken together, these results suggest that the duck pEGFP-FST
plasmid has been successfully constructed, and that it demonstrates
biological activity by promoting myoblast proliferation and
differentiation in vitro. Our preliminary studies provide groundwork0
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24 h. (a) The relative expression of FST after transfection for 12 and 24 h. (b) The relative
Y436595) were used as the internal controls. The label“**”above the bar indicates P b 0.01,
229X. Li et al. / Electronic Journal of Biotechnology 17 (2014) 224–229for further research on the roles of FST in duck myoblasts, and pave the
way for future studies of the intracellular downstream signaling
mechanisms responsible for FST's ability to promote duck muscle
development.
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